OncoImmune logo

OncoImmune

A clinical-stage biopharmaceutical company engaging in drug discovery and drug development for treating autoimmune disease and cancer.

5

Funding Rounds

$76.5m

Money raised

Overview

A clinical-stage biopharmaceutical company engaging in drug discovery and drug development for treating autoimmune disease and cancer.

Funding

Funding series

Funding Series Analysis

The company OncoImmune has raised a total of $20.5m in funding over 5 rounds.

Key Insights:

  • OncoImmune, Inc. funding round, April 2020: $1.5m
  • OncoImmune Grant (money), July 2018: $2m
  • OncoImmune Grant (money), September 2017: $2m
  • OncoImmune Series A round, January 2017: $15m
  • OncoImmune Series B round September 2020: $56m
OncoImmune logo
OncoImmune, Inc. funding round, April 2020 $1.5m
OncoImmune logo
OncoImmune Grant (money), July 2018 $2m
OncoImmune logo
OncoImmune Grant (money), September 2017 $2m
OncoImmune logo
OncoImmune Series A round, January 2017 $15m
OncoImmune logo
OncoImmune Series B round September 2020 $56m